Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Gains from Investment Securities (2016 - 2025)

Ironwood Pharmaceuticals' Gains from Investment Securities history spans 17 years, with the latest figure at $3000.0 for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities fell 99.63% to $3000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $803000.0, a 8.96% increase, with the full-year FY2025 number at $1.1 million, down 74.87% from a year prior.
  • Gains from Investment Securities hit $3000.0 in Q4 2025 for Ironwood Pharmaceuticals, up from -$7000.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for IRWD hit a ceiling of $10.0 million in Q4 2023 and a floor of -$6.6 million in Q3 2021.
  • Historically, Gains from Investment Securities has averaged $282562.5 across 5 years, with a median of -$26000.0 in 2023.
  • Biggest five-year swings in Gains from Investment Securities: plummeted 25581.25% in 2021 and later skyrocketed 242.1% in 2022.
  • Tracing IRWD's Gains from Investment Securities over 5 years: stood at -$4.2 million in 2021, then skyrocketed by 242.1% to $5.9 million in 2022, then skyrocketed by 68.03% to $10.0 million in 2023, then plummeted by 91.85% to $812000.0 in 2024, then crashed by 99.63% to $3000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for IRWD at $3000.0 in Q4 2025, -$7000.0 in Q3 2025, and $812000.0 in Q4 2024.